These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10442345)
1. Rising PSA after local therapy failure: immediate vs deferred treatment. Moul JW Oncology (Williston Park); 1999 Jul; 13(7):985-90, 993; discussion 993-5, 999. PubMed ID: 10442345 [TBL] [Abstract][Full Text] [Related]
2. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495 [TBL] [Abstract][Full Text] [Related]
3. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen. Zagars GK; Pollack A; von Eschenbach AC Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892 [TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen only progression of prostate cancer. Moul JW J Urol; 2000 Jun; 163(6):1632-42. PubMed ID: 10799151 [TBL] [Abstract][Full Text] [Related]
6. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Tzou K; Tan WW; Buskirk S Expert Rev Anticancer Ther; 2011 Jan; 11(1):125-36. PubMed ID: 21166517 [TBL] [Abstract][Full Text] [Related]
7. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066 [TBL] [Abstract][Full Text] [Related]
8. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716 [TBL] [Abstract][Full Text] [Related]
9. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow. Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849 [TBL] [Abstract][Full Text] [Related]
10. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Do T; Parker RG; Do C; Tran L; Do L; Dolkar D Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297 [TBL] [Abstract][Full Text] [Related]
11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]